Robert E Funck Insider Trading $ABT ABBOTT LABORATORIES
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E Funck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert E Funck. Robert E Funck is EXECUTIVE VICE PRESIDENT in ABBOTT LABORATORIES ($ABT) and Executive Vice President & CFO in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Vice President, Controller in ABBOTT LABORATORIES ($ABT).
Robert E Funck in ABBOTT LABORATORIES
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert E Funck: Executive Vice President & CFO, Senior Vice President, Vice President, Controller
Holdings: 188,650 shares
Current Value: $8,091,199
Latest Transaction: Apr 30 2021
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert E Funck in ABBOTT LABORATORIES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Gift | G | 0.00 | 700 | 0 | 188,650 | 189.4 K to 188.7 K (-0.37 %) |
| Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Option Exercise | A | 124.04 | 123,966 | 15,376,743 | 123,966 | |
| Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Grant | A | 0.00 | 24,185 | 0 | 199,486 | 175.3 K to 199.5 K (+13.80 %) |
| Feb 04 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Option Exercise | M | 39.12 | 31,325 | 1,225,434 | 0 | |
| Feb 04 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Payment of Exercise | F | 122.54 | 18,241 | 2,235,252 | 175,301 | 193.5 K to 175.3 K (-9.42 %) |
| Feb 04 2021 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Buy | M | 39.12 | 31,325 | 1,225,434 | 193,542 | 162.2 K to 193.5 K (+19.31 %) |
| Dec 18 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Gift | G | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 18 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Gift | G | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 18 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | EXECUTIVE VICE PRES ... | Gift | G | 0.00 | 20,000 | 0 | 162,217 | 182.2 K to 162.2 K (-10.98 %) |
| Oct 28 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 38.40 | 83,333 | 3,199,987 | 0 | |
| Oct 28 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Sell | S | 108.83 | 83,333 | 9,068,955 | 182,217 | 265.6 K to 182.2 K (-31.38 %) |
| Oct 28 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 38.40 | 83,333 | 3,199,987 | 265,550 | 182.2 K to 265.6 K (+45.73 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
| Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Sell | S | 77.89 | 1,356 | 105,619 | 169,372 | 170.7 K to 169.4 K (-0.79 %) |
| Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 6,710 | 531,365 | 170,728 | 177.4 K to 170.7 K (-3.78 %) |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | A | 87.72 | 154,013 | 13,510,020 | 154,013 | |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Grant | A | 0.00 | 25,265 | 0 | 177,438 | 152.2 K to 177.4 K (+16.60 %) |
| Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 34.94 | 40,000 | 1,397,600 | 23,700 | |
| Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Payment of Exercise | F | 85.56 | 26,818 | 2,294,548 | 152,173 | 179 K to 152.2 K (-14.98 %) |
| Aug 13 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 34.94 | 40,000 | 1,397,600 | 178,991 | 139 K to 179 K (+28.78 %) |
| Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | A | 75.90 | 122,367 | 9,287,655 | 122,367 | |
| Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Grant | A | 0.00 | 23,344 | 0 | 144,673 | 121.3 K to 144.7 K (+19.24 %) |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 27.03 | 14,400 | 389,284 | 0 | |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 22.39 | 12,300 | 275,420 | 0 | |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Option Exercise | M | 26.19 | 9,700 | 254,023 | 0 | |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Payment of Exercise | F | 67.11 | 23,751 | 1,593,930 | 121,329 | 145.1 K to 121.3 K (-16.37 %) |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 27.03 | 14,400 | 389,284 | 145,080 | 130.7 K to 145.1 K (+11.02 %) |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 22.39 | 12,300 | 275,420 | 130,680 | 118.4 K to 130.7 K (+10.39 %) |
| Sep 07 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Buy | M | 26.19 | 9,700 | 254,023 | 118,380 | 108.7 K to 118.4 K (+8.93 %) |
| Mar 02 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Sell | S | 58.99 | 1,220 | 71,970 | 104,493 | 105.7 K to 104.5 K (-1.15 %) |
| Mar 02 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Senior Vice Preside ... | Payment of Exercise | F | 60.55 | 2,654 | 160,700 | 105,713 | 108.4 K to 105.7 K (-2.45 %) |
| Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 59.94 | 110,146 | 6,602,151 | 110,146 | |
| Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 20,030 | 0 | 108,367 | 88.3 K to 108.4 K (+22.67 %) |
| Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 45.46 | 3,742 | 170,111 | 88,337 | 92.1 K to 88.3 K (-4.06 %) |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 26.70 | 25,500 | 680,781 | 0 | |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 45.50 | 25,500 | 1,160,250 | 92,079 | 117.6 K to 92.1 K (-21.69 %) |
| Feb 24 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 26.70 | 25,500 | 680,781 | 117,579 | 92.1 K to 117.6 K (+27.69 %) |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 44.40 | 48,831 | 2,168,096 | 48,831 | |
| Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 7,060 | 0 | 92,079 | 85 K to 92.1 K (+8.30 %) |
| Jul 27 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 25.25 | 26,800 | 676,595 | 0 | |
| Jul 27 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 43.08 | 26,800 | 1,154,544 | 85,019 | 111.8 K to 85 K (-23.97 %) |
| Jul 27 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 25.25 | 26,800 | 676,595 | 111,819 | 85 K to 111.8 K (+31.52 %) |
| Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 39.30 | 300 | 11,791 | 85,019 | 85.3 K to 85 K (-0.35 %) |
| Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 39.30 | 100 | 3,930 | 85,319 | 85.4 K to 85.3 K (-0.12 %) |
| Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 39.31 | 933 | 36,672 | 85,419 | 86.4 K to 85.4 K (-1.08 %) |
| Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 39.52 | 2,838 | 112,158 | 86,352 | 89.2 K to 86.4 K (-3.18 %) |
| Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 38.40 | 83,333 | 3,199,987 | 83,333 | |
| Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 9,505 | 0 | 89,190 | 79.7 K to 89.2 K (+11.93 %) |
| Jul 30 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 21.22 | 26,000 | 551,704 | 0 | |
| Jul 30 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 50.94 | 17,763 | 904,847 | 79,685 | 97.4 K to 79.7 K (-18.23 %) |
| Jul 30 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 21.22 | 26,000 | 551,704 | 97,448 | 71.4 K to 97.4 K (+36.39 %) |
| Mar 03 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 47.61 | 2,922 | 139,116 | 71,448 | 74.4 K to 71.4 K (-3.93 %) |
| Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 47.00 | 55,097 | 2,589,559 | 55,097 | |
| Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 7,819 | 0 | 74,370 | 66.6 K to 74.4 K (+11.75 %) |
| Feb 17 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 22.27 | 10,542 | 234,739 | 0 | |
| Feb 17 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 45.22 | 6,917 | 312,787 | 66,551 | 73.5 K to 66.6 K (-9.41 %) |
| Feb 17 2015 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 22.27 | 10,542 | 234,739 | 73,468 | 62.9 K to 73.5 K (+16.75 %) |
| Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 38.97 | 700 | 27,282 | 62,926 | 63.6 K to 62.9 K (-1.10 %) |
| Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 38.97 | 713 | 27,786 | 63,626 | 64.3 K to 63.6 K (-1.11 %) |
| Mar 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Payment of Exercise | F | 39.79 | 3,129 | 124,503 | 64,339 | 67.5 K to 64.3 K (-4.64 %) |
| Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | A | 39.12 | 44,325 | 1,733,994 | 44,325 | |
| Feb 25 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Grant | A | 0.00 | 7,240 | 0 | 67,468 | 60.2 K to 67.5 K (+12.02 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 35.08 | 1,546 | 54,234 | 0 | |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 33.88 | 5,715 | 193,624 | 0 | |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Option Exercise | M | 31.61 | 2,137 | 67,547 | 0 | |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 36.21 | 1,192 | 43,162 | 60,228 | 61.4 K to 60.2 K (-1.94 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 36.20 | 5,608 | 203,010 | 61,420 | 67 K to 61.4 K (-8.37 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Sell | S | 36.19 | 2,598 | 94,022 | 67,028 | 69.6 K to 67 K (-3.73 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 35.08 | 1,546 | 54,234 | 69,626 | 68.1 K to 69.6 K (+2.27 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 33.88 | 5,715 | 193,624 | 68,080 | 62.4 K to 68.1 K (+9.16 %) |
| Feb 04 2014 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Vice President, Con ... | Buy | M | 31.61 | 2,137 | 67,547 | 62,365 | 60.2 K to 62.4 K (+3.55 %) |
Page: 1